DSM-Firmenich completes EUR 540 million buyback of DSM-Firmenich stock
Published on 10/17/2026 at 11:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBuyback and upcoming dates
- The company completed a EUR 540.00 million share repurchase program on October 1, 2026.
- DSM-Firmenich intends to cancel 6,488,446 shares by the end of the first quarter of 2027.
- The next Xetra session is scheduled for October 19, 2026.
- The company will participate in a SupplySide Global panel on October 27, 2026.
DSM-Firmenich completed a EUR 540.00 million share repurchase program on October 1, 2026, according to a Globenewswire release. The program covered 7,169,147 shares at an average price of EUR 75.32. The company said it intends to cancel 6,488,446 shares by the end of the first quarter of 2027.
Market context: Market report SMI.
Weekend trading
The next price is shown from the start of trading by the continuously updated real-time quote of DSM-Firmenich stock.
Last Xetra session
The next Xetra session is scheduled for October 19, 2026. The Lang & Schwarz page recorded its most recent dated quote on October 16, 2026.
Company announcements
On October 5, 2026, DSM-Firmenich announced that it will present “The Longevity Shift 2.0: The Gut Effect” at SupplySide Global 2026 from October 28 through October 30, 2026. The company also said a representative will join a panel on October 27, 2026, according to the company release.
Dates of the coming week
The calendar includes the October 19, 2026 Xetra session, the October 27, 2026 industry panel and the October 28 through October 30, 2026 SupplySide Global event.
